Does menopause and aging lower estradiol and androgens?

Physiological and hormonal shift

The transition through menopause and the progression of aging are characterized by profound endocrine changes that alter a woman's hormonal profile:

• Precipitously falling estradiol: During reproductive years, cyclic ovarian estradiol levels range from 30 to over 400 pg/mL. Following menopause, critical follicular depletion causes a near-total cessation of ovarian estradiol synthesis. Circulating levels drop by up to 67% across the transition, stabilizing at a non-cyclic range of just 2 to 21 pg/mL.
• Gradual androgen decline: Unlike estradiol, which drops sharply at menopause, androgens (including testosterone, DHEA, and DHEAS) decline progressively with chronological aging starting in a woman's 20s and 30s. By age 40, total and free androgen levels are reduced by approximately 50% from their peak, driven by the aging of the adrenal zona reticularis and progressive ovarian follicular depletion.

Clinical and metabolic impacts

The concurrent loss of these hormones directly impairs physical energy, metabolic health, and musculoskeletal integrity:

• Low energy and fatigue: The drop in estradiol disrupts hypothalamic energy regulation and causes mitochondrial dysfunction. This lowers the resting metabolic rate and blunts fat oxidation, presenting clinically as physical fatigue.
• Unfavorable body composition: Estradiol deficiency shifts fat storage from subcutaneous to visceral depots, while a lack of anabolic stimulus from declining testosterone promotes sarcopenia (muscle loss) and muscle fat infiltration.
• Reduced tissue resilience: Estrogen is essential for connective tissue maintenance. Within five years of menopause, women lose up to 30% of dermal and structural collagen. This, combined with declining hyaluronic acid and age-related muscle wasting from low testosterone, leads to joint fragility, reduced skin elasticity, and decreased muscle strength.

Bottom line

The claims are fully supported by science. The menopausal drop in estradiol and the age-related decline in androgens work synergistically to reduce resting metabolic rate, drive visceral fat accumulation and sarcopenia, and degrade connective tissue structural resilience.